Postbiotic Market By Form (Powder, Liquid, Others), By Application (Personal Care and Cosmetics, Food and Beverage, Animal Feed, Pharmaceuticals, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
The postbiotics market was valued at $1,579.0 million in 2021, and is estimated to reach $3,025.8 million by 2031, registering a CAGR of 6.8% from 2022 to 2031. In 2021, the powdered postbiotic segment accounted for the majority of the total postbiotic market. Postbiotics are soluble factors that provide physiological benefits to the host and are secreted by live bacteria or released after bacterial lysis. Metabiotics, biogenic, and metabolites are other names for postbiotics, and they are most commonly used as supplements and cosmetics.
The demand for various types of nutraceutical products is rapidly increasing. The primary reason for the increase in demand is growing awareness of the health benefits of using nutraceuticals and nutraceutical supplements. Furthermore, the adoption of hectic lifestyles due to work pressure, combined with increased consumption of fast and unhealthy foods, is driving consumers to seek out supplements that can help them maintain their health and well-being. Fast food consumption is increasing, which is causing diseases such as high cholesterol, obesity, bone degeneration, and heart disease. More and more people are engaging in fitness activities such as visiting gyms and athletic centers to maintain their health, and they are combining these activities with postbiotic nutraceuticals to achieve the best results.
Consumer lifestyle changes have been one of the major factors contributing to the growing popularity of functional foods and beverages in developing economies. Customers' food habits are changing in Asia-Pacific countries as per capita income rises. The rise in aspiration and preference for a luxurious lifestyle has resulted in a significant increase in market size and overall demand. Functional beverages are made up of specific nutrients and supplements, such as probiotics, which improve athletic performance and metabolism. Appropriate nutrition is a necessary prerequisite for effective athletic performance improvement, conditioning, recovery from fatigue after exercise, and rapid injury recovery. It also aids in the management of diabetes. As a result, the demand for functional beverages such as natural sports and energy drinks is rapidly increasing.
The difficulties that manufacturers face during the manufacturing process impede the postbiotic market. Many times, the extraction of the ingredients required to make postbiotics is difficult, and the end result is a very small amount of the ingredient. The ingredient's stability is also important, as many nutraceutical ingredients are highly unstable and decompose quickly in unfavorable conditions. As a result, these ingredients must be carefully stored and handled, which sometimes necessitates large investments in equipment. Furthermore, due to the various textures and forms of the ingredients, manufacturing postbiotics can be difficult at times, making it difficult for the engaged stakeholders to manufacture such types of nutraceuticals.
Postbiotics are becoming increasingly popular as more consumers add nutraceuticals to their regular diets. However, many consumers are looking for supplements that are both convenient and tasty, making such products easier to consume. Newer types of nutraceuticals, such as gummies, jellies, and soft gels, are being introduced to the market, and their popularity is growing. They come in a variety of shapes, sizes, flavors, and concentrations. Most of these nutraceuticals are intended for daily consumption, and thus these varieties allow consumers to consume these nutraceuticals on a daily basis if they are perceived to be enjoyable to consume. Furthermore, these types of nutraceuticals are becoming increasingly popular among children.
The postbiotic market is segmented on the basis of form, application, and region. By form, the postbiotic market is classified into powder, liquid, and others. Depending on the application, the market is categorized into personal care and cosmetics, food and beverage, animal feed, pharmaceuticals, and others. Region-wise, the market is divided into North America, Europe, Asia-Pacific, and LAMEA.
Some of the major players analyzed in this report are Sami-Sabinsa Group Limited, Woresan GmbH, Novachem SRL, ILDONG HOLDINGS CO., LTD., Church & Dwight Co., Inc., Danish Agro, Lamberti S.p.A., Cargill, Incorporated, Adare Pharma Solutions, Lactobio A/S, Archer Daniels Midland Company, Kirin Holdings Company, Limited, Bioflag Group, Probiotics Australia Pty., Ltd., Lesaffre, Otemchi Biotechnologies Pte. Ltd., SILAB, Mitsubishi Corporation, GeneFerm Biotechnology Co., Ltd., and KOREA BeRM co., Ltd.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the postbiotic market analysis from 2021 to 2031 to identify the prevailing postbiotic market opportunities.
Market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights buyers' and suppliers' potency to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
An in-depth analysis of the postbiotic market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global postbiotic market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Form
Powder
Liquid
Others
By Application
Personal Care and Cosmetics
Food and Beverage
Animal Feed
Pharmaceuticals
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Netherlands
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Latin America
Middle East
Africa
Key Market Players
Adare Pharma Solutions
Church & Dwight Co., Inc.
Danish Agro
woresan GmbH
ILDONG HOLDINGS CO., LTD.
Sami-Sabinsa Group Limited
Lesaffre
Bioflag Group
Archer Daniels Midland Company
Otemchi Biotechnologies Pte. Ltd.
GeneFerm Biotechnology Co., Ltd.
Mitsubishi Corporation
Probiotics Australia Pty., Ltd.
Cargill, Incorporated
Lactobio A/S
SILAB
KOREA BeRM co., Ltd
Novachem SRL
Kirin Holdings Company, Limited
Lamberti S.p.A.
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: POSTBIOTIC MARKET, BY FORM
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Powder
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market share analysis by country
- 4.3 Liquid
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market share analysis by country
- 4.4 Others
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market share analysis by country
- CHAPTER 5: POSTBIOTIC MARKET, BY APPLICATION
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Personal Care and Cosmetics
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market share analysis by country
- 5.3 Food and Beverage
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market share analysis by country
- 5.4 Animal Feed
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market share analysis by country
- 5.5 Pharmaceuticals
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market share analysis by country
- 5.6 Others
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market share analysis by country
- CHAPTER 6: POSTBIOTIC MARKET, BY REGION
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 North America
- 6.2.1 Key trends and opportunities
- 6.2.2 North America Market size and forecast, by Form
- 6.2.3 North America Market size and forecast, by Application
- 6.2.4 North America Market size and forecast, by country
- 6.2.4.1 U.S.
- 6.2.4.1.1 Key market trends, growth factors and opportunities
- 6.2.4.1.2 Market size and forecast, by Form
- 6.2.4.1.3 Market size and forecast, by Application
- 6.2.4.2 Canada
- 6.2.4.2.1 Key market trends, growth factors and opportunities
- 6.2.4.2.2 Market size and forecast, by Form
- 6.2.4.2.3 Market size and forecast, by Application
- 6.2.4.3 Mexico
- 6.2.4.3.1 Key market trends, growth factors and opportunities
- 6.2.4.3.2 Market size and forecast, by Form
- 6.2.4.3.3 Market size and forecast, by Application
- 6.3 Europe
- 6.3.1 Key trends and opportunities
- 6.3.2 Europe Market size and forecast, by Form
- 6.3.3 Europe Market size and forecast, by Application
- 6.3.4 Europe Market size and forecast, by country
- 6.3.4.1 Germany
- 6.3.4.1.1 Key market trends, growth factors and opportunities
- 6.3.4.1.2 Market size and forecast, by Form
- 6.3.4.1.3 Market size and forecast, by Application
- 6.3.4.2 France
- 6.3.4.2.1 Key market trends, growth factors and opportunities
- 6.3.4.2.2 Market size and forecast, by Form
- 6.3.4.2.3 Market size and forecast, by Application
- 6.3.4.3 UK
- 6.3.4.3.1 Key market trends, growth factors and opportunities
- 6.3.4.3.2 Market size and forecast, by Form
- 6.3.4.3.3 Market size and forecast, by Application
- 6.3.4.4 Italy
- 6.3.4.4.1 Key market trends, growth factors and opportunities
- 6.3.4.4.2 Market size and forecast, by Form
- 6.3.4.4.3 Market size and forecast, by Application
- 6.3.4.5 Spain
- 6.3.4.5.1 Key market trends, growth factors and opportunities
- 6.3.4.5.2 Market size and forecast, by Form
- 6.3.4.5.3 Market size and forecast, by Application
- 6.3.4.6 Netherlands
- 6.3.4.6.1 Key market trends, growth factors and opportunities
- 6.3.4.6.2 Market size and forecast, by Form
- 6.3.4.6.3 Market size and forecast, by Application
- 6.3.4.7 Rest of Europe
- 6.3.4.7.1 Key market trends, growth factors and opportunities
- 6.3.4.7.2 Market size and forecast, by Form
- 6.3.4.7.3 Market size and forecast, by Application
- 6.4 Asia-Pacific
- 6.4.1 Key trends and opportunities
- 6.4.2 Asia-Pacific Market size and forecast, by Form
- 6.4.3 Asia-Pacific Market size and forecast, by Application
- 6.4.4 Asia-Pacific Market size and forecast, by country
- 6.4.4.1 China
- 6.4.4.1.1 Key market trends, growth factors and opportunities
- 6.4.4.1.2 Market size and forecast, by Form
- 6.4.4.1.3 Market size and forecast, by Application
- 6.4.4.2 Japan
- 6.4.4.2.1 Key market trends, growth factors and opportunities
- 6.4.4.2.2 Market size and forecast, by Form
- 6.4.4.2.3 Market size and forecast, by Application
- 6.4.4.3 India
- 6.4.4.3.1 Key market trends, growth factors and opportunities
- 6.4.4.3.2 Market size and forecast, by Form
- 6.4.4.3.3 Market size and forecast, by Application
- 6.4.4.4 South Korea
- 6.4.4.4.1 Key market trends, growth factors and opportunities
- 6.4.4.4.2 Market size and forecast, by Form
- 6.4.4.4.3 Market size and forecast, by Application
- 6.4.4.5 Australia
- 6.4.4.5.1 Key market trends, growth factors and opportunities
- 6.4.4.5.2 Market size and forecast, by Form
- 6.4.4.5.3 Market size and forecast, by Application
- 6.4.4.6 Rest of Asia-Pacific
- 6.4.4.6.1 Key market trends, growth factors and opportunities
- 6.4.4.6.2 Market size and forecast, by Form
- 6.4.4.6.3 Market size and forecast, by Application
- 6.5 LAMEA
- 6.5.1 Key trends and opportunities
- 6.5.2 LAMEA Market size and forecast, by Form
- 6.5.3 LAMEA Market size and forecast, by Application
- 6.5.4 LAMEA Market size and forecast, by country
- 6.5.4.1 Latin America
- 6.5.4.1.1 Key market trends, growth factors and opportunities
- 6.5.4.1.2 Market size and forecast, by Form
- 6.5.4.1.3 Market size and forecast, by Application
- 6.5.4.2 Middle East
- 6.5.4.2.1 Key market trends, growth factors and opportunities
- 6.5.4.2.2 Market size and forecast, by Form
- 6.5.4.2.3 Market size and forecast, by Application
- 6.5.4.3 Africa
- 6.5.4.3.1 Key market trends, growth factors and opportunities
- 6.5.4.3.2 Market size and forecast, by Form
- 6.5.4.3.3 Market size and forecast, by Application
- CHAPTER 7: COMPANY LANDSCAPE
- 7.1. Introduction
- 7.2. Top winning strategies
- 7.3. Product Mapping of Top 10 Player
- 7.4. Competitive Dashboard
- 7.5. Competitive Heatmap
- 7.6. Key developments
- CHAPTER 8: COMPANY PROFILES
- 8.1 Sami-Sabinsa Group Limited
- 8.1.1 Company overview
- 8.1.2 Company snapshot
- 8.1.3 Operating business segments
- 8.1.4 Product portfolio
- 8.1.5 Business performance
- 8.1.6 Key strategic moves and developments
- 8.2 woresan GmbH
- 8.2.1 Company overview
- 8.2.2 Company snapshot
- 8.2.3 Operating business segments
- 8.2.4 Product portfolio
- 8.2.5 Business performance
- 8.2.6 Key strategic moves and developments
- 8.3 Novachem SRL
- 8.3.1 Company overview
- 8.3.2 Company snapshot
- 8.3.3 Operating business segments
- 8.3.4 Product portfolio
- 8.3.5 Business performance
- 8.3.6 Key strategic moves and developments
- 8.4 ILDONG HOLDINGS CO.,LTD.
- 8.4.1 Company overview
- 8.4.2 Company snapshot
- 8.4.3 Operating business segments
- 8.4.4 Product portfolio
- 8.4.5 Business performance
- 8.4.6 Key strategic moves and developments
- 8.5 Church & Dwight Co., Inc
- 8.5.1 Company overview
- 8.5.2 Company snapshot
- 8.5.3 Operating business segments
- 8.5.4 Product portfolio
- 8.5.5 Business performance
- 8.5.6 Key strategic moves and developments
- 8.6 Danish Agro
- 8.6.1 Company overview
- 8.6.2 Company snapshot
- 8.6.3 Operating business segments
- 8.6.4 Product portfolio
- 8.6.5 Business performance
- 8.6.6 Key strategic moves and developments
- 8.7 Lamberti S.p.A.
- 8.7.1 Company overview
- 8.7.2 Company snapshot
- 8.7.3 Operating business segments
- 8.7.4 Product portfolio
- 8.7.5 Business performance
- 8.7.6 Key strategic moves and developments
- 8.8 Cargill, Incorporated
- 8.8.1 Company overview
- 8.8.2 Company snapshot
- 8.8.3 Operating business segments
- 8.8.4 Product portfolio
- 8.8.5 Business performance
- 8.8.6 Key strategic moves and developments
- 8.9 Adare Pharma Solutions
- 8.9.1 Company overview
- 8.9.2 Company snapshot
- 8.9.3 Operating business segments
- 8.9.4 Product portfolio
- 8.9.5 Business performance
- 8.9.6 Key strategic moves and developments
- 8.10 Lactobio A/S
- 8.10.1 Company overview
- 8.10.2 Company snapshot
- 8.10.3 Operating business segments
- 8.10.4 Product portfolio
- 8.10.5 Business performance
- 8.10.6 Key strategic moves and developments
- 8.11 Archer Daniels Midland Company
- 8.11.1 Company overview
- 8.11.2 Company snapshot
- 8.11.3 Operating business segments
- 8.11.4 Product portfolio
- 8.11.5 Business performance
- 8.11.6 Key strategic moves and developments
- 8.12 Kirin Holdings Company, Limited.
- 8.12.1 Company overview
- 8.12.2 Company snapshot
- 8.12.3 Operating business segments
- 8.12.4 Product portfolio
- 8.12.5 Business performance
- 8.12.6 Key strategic moves and developments
- 8.13 Bioflag Group
- 8.13.1 Company overview
- 8.13.2 Company snapshot
- 8.13.3 Operating business segments
- 8.13.4 Product portfolio
- 8.13.5 Business performance
- 8.13.6 Key strategic moves and developments
- 8.14 Probiotics Australia Pty., Ltd.
- 8.14.1 Company overview
- 8.14.2 Company snapshot
- 8.14.3 Operating business segments
- 8.14.4 Product portfolio
- 8.14.5 Business performance
- 8.14.6 Key strategic moves and developments
- 8.15 Lesaffre
- 8.15.1 Company overview
- 8.15.2 Company snapshot
- 8.15.3 Operating business segments
- 8.15.4 Product portfolio
- 8.15.5 Business performance
- 8.15.6 Key strategic moves and developments
- 8.16 Otemchi Biotechnologies Pte. Ltd.,
- 8.16.1 Company overview
- 8.16.2 Company snapshot
- 8.16.3 Operating business segments
- 8.16.4 Product portfolio
- 8.16.5 Business performance
- 8.16.6 Key strategic moves and developments
- 8.17 SILAB
- 8.17.1 Company overview
- 8.17.2 Company snapshot
- 8.17.3 Operating business segments
- 8.17.4 Product portfolio
- 8.17.5 Business performance
- 8.17.6 Key strategic moves and developments
- 8.18 Mitsubishi Corporation
- 8.18.1 Company overview
- 8.18.2 Company snapshot
- 8.18.3 Operating business segments
- 8.18.4 Product portfolio
- 8.18.5 Business performance
- 8.18.6 Key strategic moves and developments
- 8.19 GeneFerm Biotechnology Co., Ltd.
- 8.19.1 Company overview
- 8.19.2 Company snapshot
- 8.19.3 Operating business segments
- 8.19.4 Product portfolio
- 8.19.5 Business performance
- 8.19.6 Key strategic moves and developments
- 8.20 KOREA BeRM co.,Ltd
- 8.20.1 Company overview
- 8.20.2 Company snapshot
- 8.20.3 Operating business segments
- 8.20.4 Product portfolio
- 8.20.5 Business performance
- 8.20.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL POSTBIOTIC MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
- TABLE 2. POSTBIOTIC MARKET, FOR POWDER, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 3. POSTBIOTIC MARKET, FOR POWDER, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 4. POSTBIOTIC MARKET, FOR LIQUID, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 5. POSTBIOTIC MARKET, FOR LIQUID, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 6. POSTBIOTIC MARKET, FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 7. POSTBIOTIC MARKET, FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 8. GLOBAL POSTBIOTIC MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 9. POSTBIOTIC MARKET, FOR PERSONAL CARE AND COSMETICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 10. POSTBIOTIC MARKET, FOR PERSONAL CARE AND COSMETICS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 11. POSTBIOTIC MARKET, FOR FOOD AND BEVERAGE, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 12. POSTBIOTIC MARKET, FOR FOOD AND BEVERAGE, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 13. POSTBIOTIC MARKET, FOR ANIMAL FEED, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 14. POSTBIOTIC MARKET, FOR ANIMAL FEED, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 15. POSTBIOTIC MARKET, FOR PHARMACEUTICALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 16. POSTBIOTIC MARKET, FOR PHARMACEUTICALS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 17. POSTBIOTIC MARKET, FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 18. POSTBIOTIC MARKET, FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 19. POSTBIOTIC MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
- TABLE 20. NORTH AMERICA POSTBIOTIC MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
- TABLE 21. NORTH AMERICA POSTBIOTIC MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 22. NORTH AMERICA POSTBIOTIC MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 23. U.S. POSTBIOTIC MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
- TABLE 24. U.S. POSTBIOTIC MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 25. CANADA POSTBIOTIC MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
- TABLE 26. CANADA POSTBIOTIC MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 27. MEXICO POSTBIOTIC MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
- TABLE 28. MEXICO POSTBIOTIC MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 29. EUROPE POSTBIOTIC MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
- TABLE 30. EUROPE POSTBIOTIC MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 31. EUROPE POSTBIOTIC MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 32. GERMANY POSTBIOTIC MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
- TABLE 33. GERMANY POSTBIOTIC MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 34. FRANCE POSTBIOTIC MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
- TABLE 35. FRANCE POSTBIOTIC MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 36. UK POSTBIOTIC MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
- TABLE 37. UK POSTBIOTIC MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 38. ITALY POSTBIOTIC MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
- TABLE 39. ITALY POSTBIOTIC MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 40. SPAIN POSTBIOTIC MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
- TABLE 41. SPAIN POSTBIOTIC MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 42. NETHERLANDS POSTBIOTIC MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
- TABLE 43. NETHERLANDS POSTBIOTIC MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 44. REST OF EUROPE POSTBIOTIC MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
- TABLE 45. REST OF EUROPE POSTBIOTIC MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 46. ASIA-PACIFIC POSTBIOTIC MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
- TABLE 47. ASIA-PACIFIC POSTBIOTIC MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 48. ASIA-PACIFIC POSTBIOTIC MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 49. CHINA POSTBIOTIC MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
- TABLE 50. CHINA POSTBIOTIC MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 51. JAPAN POSTBIOTIC MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
- TABLE 52. JAPAN POSTBIOTIC MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 53. INDIA POSTBIOTIC MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
- TABLE 54. INDIA POSTBIOTIC MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 55. SOUTH KOREA POSTBIOTIC MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
- TABLE 56. SOUTH KOREA POSTBIOTIC MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 57. AUSTRALIA POSTBIOTIC MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
- TABLE 58. AUSTRALIA POSTBIOTIC MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 59. REST OF ASIA-PACIFIC POSTBIOTIC MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
- TABLE 60. REST OF ASIA-PACIFIC POSTBIOTIC MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 61. LAMEA POSTBIOTIC MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
- TABLE 62. LAMEA POSTBIOTIC MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 63. LAMEA POSTBIOTIC MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
- TABLE 64. LATIN AMERICA POSTBIOTIC MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
- TABLE 65. LATIN AMERICA POSTBIOTIC MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 66. MIDDLE EAST POSTBIOTIC MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
- TABLE 67. MIDDLE EAST POSTBIOTIC MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 68. AFRICA POSTBIOTIC MARKET, BY FORM, 2021-2031 (REVENUE, $MILLION)
- TABLE 69. AFRICA POSTBIOTIC MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
- TABLE 70.SAMI-SABINSA GROUP LIMITED: COMPANY SNAPSHOT
- TABLE 71.SAMI-SABINSA GROUP LIMITED: OPERATING SEGMENTS
- TABLE 72.SAMI-SABINSA GROUP LIMITED: PRODUCT PORTFOLIO
- TABLE 73.SAMI-SABINSA GROUP LIMITED: NET SALES,
- TABLE 74.SAMI-SABINSA GROUP LIMITED: KEY STRATERGIES
- TABLE 75.WORESAN GMBH: COMPANY SNAPSHOT
- TABLE 76.WORESAN GMBH: OPERATING SEGMENTS
- TABLE 77.WORESAN GMBH: PRODUCT PORTFOLIO
- TABLE 78.WORESAN GMBH: NET SALES,
- TABLE 79.WORESAN GMBH: KEY STRATERGIES
- TABLE 80.NOVACHEM SRL: COMPANY SNAPSHOT
- TABLE 81.NOVACHEM SRL: OPERATING SEGMENTS
- TABLE 82.NOVACHEM SRL: PRODUCT PORTFOLIO
- TABLE 83.NOVACHEM SRL: NET SALES,
- TABLE 84.NOVACHEM SRL: KEY STRATERGIES
- TABLE 85.ILDONG HOLDINGS CO.,LTD.: COMPANY SNAPSHOT
- TABLE 86.ILDONG HOLDINGS CO.,LTD.: OPERATING SEGMENTS
- TABLE 87.ILDONG HOLDINGS CO.,LTD.: PRODUCT PORTFOLIO
- TABLE 88.ILDONG HOLDINGS CO.,LTD.: NET SALES,
- TABLE 89.ILDONG HOLDINGS CO.,LTD.: KEY STRATERGIES
- TABLE 90.CHURCH & DWIGHT CO., INC: COMPANY SNAPSHOT
- TABLE 91.CHURCH & DWIGHT CO., INC: OPERATING SEGMENTS
- TABLE 92.CHURCH & DWIGHT CO., INC: PRODUCT PORTFOLIO
- TABLE 93.CHURCH & DWIGHT CO., INC: NET SALES,
- TABLE 94.CHURCH & DWIGHT CO., INC: KEY STRATERGIES
- TABLE 95.DANISH AGRO: COMPANY SNAPSHOT
- TABLE 96.DANISH AGRO: OPERATING SEGMENTS
- TABLE 97.DANISH AGRO: PRODUCT PORTFOLIO
- TABLE 98.DANISH AGRO: NET SALES,
- TABLE 99.DANISH AGRO: KEY STRATERGIES
- TABLE 100.LAMBERTI S.P.A.: COMPANY SNAPSHOT
- TABLE 101.LAMBERTI S.P.A.: OPERATING SEGMENTS
- TABLE 102.LAMBERTI S.P.A.: PRODUCT PORTFOLIO
- TABLE 103.LAMBERTI S.P.A.: NET SALES,
- TABLE 104.LAMBERTI S.P.A.: KEY STRATERGIES
- TABLE 105.CARGILL, INCORPORATED: COMPANY SNAPSHOT
- TABLE 106.CARGILL, INCORPORATED: OPERATING SEGMENTS
- TABLE 107.CARGILL, INCORPORATED: PRODUCT PORTFOLIO
- TABLE 108.CARGILL, INCORPORATED: NET SALES,
- TABLE 109.CARGILL, INCORPORATED: KEY STRATERGIES
- TABLE 110.ADARE PHARMA SOLUTIONS: COMPANY SNAPSHOT
- TABLE 111.ADARE PHARMA SOLUTIONS: OPERATING SEGMENTS
- TABLE 112.ADARE PHARMA SOLUTIONS: PRODUCT PORTFOLIO
- TABLE 113.ADARE PHARMA SOLUTIONS: NET SALES,
- TABLE 114.ADARE PHARMA SOLUTIONS: KEY STRATERGIES
- TABLE 115.LACTOBIO A/S: COMPANY SNAPSHOT
- TABLE 116.LACTOBIO A/S: OPERATING SEGMENTS
- TABLE 117.LACTOBIO A/S: PRODUCT PORTFOLIO
- TABLE 118.LACTOBIO A/S: NET SALES,
- TABLE 119.LACTOBIO A/S: KEY STRATERGIES
- TABLE 120.ARCHER DANIELS MIDLAND COMPANY: COMPANY SNAPSHOT
- TABLE 121.ARCHER DANIELS MIDLAND COMPANY: OPERATING SEGMENTS
- TABLE 122.ARCHER DANIELS MIDLAND COMPANY: PRODUCT PORTFOLIO
- TABLE 123.ARCHER DANIELS MIDLAND COMPANY: NET SALES,
- TABLE 124.ARCHER DANIELS MIDLAND COMPANY: KEY STRATERGIES
- TABLE 125.KIRIN HOLDINGS COMPANY, LIMITED.: COMPANY SNAPSHOT
- TABLE 126.KIRIN HOLDINGS COMPANY, LIMITED.: OPERATING SEGMENTS
- TABLE 127.KIRIN HOLDINGS COMPANY, LIMITED.: PRODUCT PORTFOLIO
- TABLE 128.KIRIN HOLDINGS COMPANY, LIMITED.: NET SALES,
- TABLE 129.KIRIN HOLDINGS COMPANY, LIMITED.: KEY STRATERGIES
- TABLE 130.BIOFLAG GROUP: COMPANY SNAPSHOT
- TABLE 131.BIOFLAG GROUP: OPERATING SEGMENTS
- TABLE 132.BIOFLAG GROUP: PRODUCT PORTFOLIO
- TABLE 133.BIOFLAG GROUP: NET SALES,
- TABLE 134.BIOFLAG GROUP: KEY STRATERGIES
- TABLE 135.PROBIOTICS AUSTRALIA PTY., LTD.: COMPANY SNAPSHOT
- TABLE 136.PROBIOTICS AUSTRALIA PTY., LTD.: OPERATING SEGMENTS
- TABLE 137.PROBIOTICS AUSTRALIA PTY., LTD.: PRODUCT PORTFOLIO
- TABLE 138.PROBIOTICS AUSTRALIA PTY., LTD.: NET SALES,
- TABLE 139.PROBIOTICS AUSTRALIA PTY., LTD.: KEY STRATERGIES
- TABLE 140.LESAFFRE: COMPANY SNAPSHOT
- TABLE 141.LESAFFRE: OPERATING SEGMENTS
- TABLE 142.LESAFFRE: PRODUCT PORTFOLIO
- TABLE 143.LESAFFRE: NET SALES,
- TABLE 144.LESAFFRE: KEY STRATERGIES
- TABLE 145.OTEMCHI BIOTECHNOLOGIES PTE. LTD.,: COMPANY SNAPSHOT
- TABLE 146.OTEMCHI BIOTECHNOLOGIES PTE. LTD.,: OPERATING SEGMENTS
- TABLE 147.OTEMCHI BIOTECHNOLOGIES PTE. LTD.,: PRODUCT PORTFOLIO
- TABLE 148.OTEMCHI BIOTECHNOLOGIES PTE. LTD.,: NET SALES,
- TABLE 149.OTEMCHI BIOTECHNOLOGIES PTE. LTD.,: KEY STRATERGIES
- TABLE 150.SILAB: COMPANY SNAPSHOT
- TABLE 151.SILAB: OPERATING SEGMENTS
- TABLE 152.SILAB: PRODUCT PORTFOLIO
- TABLE 153.SILAB: NET SALES,
- TABLE 154.SILAB: KEY STRATERGIES
- TABLE 155.MITSUBISHI CORPORATION: COMPANY SNAPSHOT
- TABLE 156.MITSUBISHI CORPORATION: OPERATING SEGMENTS
- TABLE 157.MITSUBISHI CORPORATION: PRODUCT PORTFOLIO
- TABLE 158.MITSUBISHI CORPORATION: NET SALES,
- TABLE 159.MITSUBISHI CORPORATION: KEY STRATERGIES
- TABLE 160.GENEFERM BIOTECHNOLOGY CO., LTD.: COMPANY SNAPSHOT
- TABLE 161.GENEFERM BIOTECHNOLOGY CO., LTD.: OPERATING SEGMENTS
- TABLE 162.GENEFERM BIOTECHNOLOGY CO., LTD.: PRODUCT PORTFOLIO
- TABLE 163.GENEFERM BIOTECHNOLOGY CO., LTD.: NET SALES,
- TABLE 164.GENEFERM BIOTECHNOLOGY CO., LTD.: KEY STRATERGIES
- TABLE 165.KOREA BERM CO.,LTD: COMPANY SNAPSHOT
- TABLE 166.KOREA BERM CO.,LTD: OPERATING SEGMENTS
- TABLE 167.KOREA BERM CO.,LTD: PRODUCT PORTFOLIO
- TABLE 168.KOREA BERM CO.,LTD: NET SALES,
- TABLE 169.KOREA BERM CO.,LTD: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.POSTBIOTIC MARKET SEGMENTATION
- FIGURE 2.POSTBIOTIC MARKET,2021-2031
- FIGURE 3.POSTBIOTIC MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.POSTBIOTIC MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.POSTBIOTIC MARKET,BY FORM,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF POWDER POSTBIOTIC MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF LIQUID POSTBIOTIC MARKET,2021-2031(%)
- FIGURE 15.COMPARATIVE SHARE ANALYSIS OF OTHERS POSTBIOTIC MARKET,2021-2031(%)
- FIGURE 16.POSTBIOTIC MARKET,BY APPLICATION,2021(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF PERSONAL CARE AND COSMETICS POSTBIOTIC MARKET,2021-2031(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF FOOD AND BEVERAGE POSTBIOTIC MARKET,2021-2031(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF ANIMAL FEED POSTBIOTIC MARKET,2021-2031(%)
- FIGURE 20.COMPARATIVE SHARE ANALYSIS OF PHARMACEUTICALS POSTBIOTIC MARKET,2021-2031(%)
- FIGURE 21.COMPARATIVE SHARE ANALYSIS OF OTHERS POSTBIOTIC MARKET,2021-2031(%)
- FIGURE 22.POSTBIOTIC MARKET BY REGION,2021
- FIGURE 23.U.S. POSTBIOTIC MARKET,2021-2031($MILLION)
- FIGURE 24.CANADA POSTBIOTIC MARKET,2021-2031($MILLION)
- FIGURE 25.MEXICO POSTBIOTIC MARKET,2021-2031($MILLION)
- FIGURE 26.GERMANY POSTBIOTIC MARKET,2021-2031($MILLION)
- FIGURE 27.FRANCE POSTBIOTIC MARKET,2021-2031($MILLION)
- FIGURE 28.UK POSTBIOTIC MARKET,2021-2031($MILLION)
- FIGURE 29.ITALY POSTBIOTIC MARKET,2021-2031($MILLION)
- FIGURE 30.SPAIN POSTBIOTIC MARKET,2021-2031($MILLION)
- FIGURE 31.NETHERLANDS POSTBIOTIC MARKET,2021-2031($MILLION)
- FIGURE 32.REST OF EUROPE POSTBIOTIC MARKET,2021-2031($MILLION)
- FIGURE 33.CHINA POSTBIOTIC MARKET,2021-2031($MILLION)
- FIGURE 34.JAPAN POSTBIOTIC MARKET,2021-2031($MILLION)
- FIGURE 35.INDIA POSTBIOTIC MARKET,2021-2031($MILLION)
- FIGURE 36.SOUTH KOREA POSTBIOTIC MARKET,2021-2031($MILLION)
- FIGURE 37.AUSTRALIA POSTBIOTIC MARKET,2021-2031($MILLION)
- FIGURE 38.REST OF ASIA-PACIFIC POSTBIOTIC MARKET,2021-2031($MILLION)
- FIGURE 39.LATIN AMERICA POSTBIOTIC MARKET,2021-2031($MILLION)
- FIGURE 40.MIDDLE EAST POSTBIOTIC MARKET,2021-2031($MILLION)
- FIGURE 41.AFRICA POSTBIOTIC MARKET,2021-2031($MILLION)
- FIGURE 42. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 45.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 46.COMPETITIVE DASHBOARD
- FIGURE 47.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 48.SAMI-SABINSA GROUP LIMITED.: NET SALES ($MILLION)
- FIGURE 49.WORESAN GMBH.: NET SALES ($MILLION)
- FIGURE 50.NOVACHEM SRL.: NET SALES ($MILLION)
- FIGURE 51.ILDONG HOLDINGS CO.,LTD..: NET SALES ($MILLION)
- FIGURE 52.CHURCH & DWIGHT CO., INC.: NET SALES ($MILLION)
- FIGURE 53.DANISH AGRO.: NET SALES ($MILLION)
- FIGURE 54.LAMBERTI S.P.A..: NET SALES ($MILLION)
- FIGURE 55.CARGILL, INCORPORATED.: NET SALES ($MILLION)
- FIGURE 56.ADARE PHARMA SOLUTIONS.: NET SALES ($MILLION)
- FIGURE 57.LACTOBIO A/S.: NET SALES ($MILLION)
- FIGURE 58.ARCHER DANIELS MIDLAND COMPANY.: NET SALES ($MILLION)
- FIGURE 59.KIRIN HOLDINGS COMPANY, LIMITED..: NET SALES ($MILLION)
- FIGURE 60.BIOFLAG GROUP.: NET SALES ($MILLION)
- FIGURE 61.PROBIOTICS AUSTRALIA PTY., LTD..: NET SALES ($MILLION)
- FIGURE 62.LESAFFRE.: NET SALES ($MILLION)
- FIGURE 63.OTEMCHI BIOTECHNOLOGIES PTE. LTD.,.: NET SALES ($MILLION)
- FIGURE 64.SILAB.: NET SALES ($MILLION)
- FIGURE 65.MITSUBISHI CORPORATION.: NET SALES ($MILLION)
- FIGURE 66.GENEFERM BIOTECHNOLOGY CO., LTD..: NET SALES ($MILLION)
- FIGURE 67.KOREA BERM CO.,LTD.: NET SALES ($MILLION)
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook